Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1986 1
1987 1
1989 1
1990 1
1991 3
1992 3
1993 2
1994 2
1995 1
1996 3
1997 3
1998 6
1999 1
2000 6
2001 6
2002 6
2003 15
2004 6
2005 5
2006 6
2007 9
2008 10
2009 17
2010 12
2011 13
2012 16
2013 6
2014 5
2015 11
2016 14
2017 22
2018 20
2019 15
2020 12
2021 18
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

252 results
Results by year
Filters applied: . Clear all
Page 1
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study.
Kosiborod M, Lam CSP, Kohsaka S, Kim DJ, Karasik A, Shaw J, Tangri N, Goh SY, Thuresson M, Chen H, Surmont F, Hammar N, Fenici P; CVD-REAL Investigators and Study Group. Kosiborod M, et al. Among authors: hammar n. J Am Coll Cardiol. 2018 Jun 12;71(23):2628-2639. doi: 10.1016/j.jacc.2018.03.009. Epub 2018 Mar 11. J Am Coll Cardiol. 2018. PMID: 29540325 Free article. Clinical Trial.
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).
Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen ME, Thuresson M, Arya N, Bodegård J, Hammar N, Fenici P; CVD-REAL Investigators and Study Group*. Kosiborod M, et al. Among authors: hammar n. Circulation. 2017 Jul 18;136(3):249-259. doi: 10.1161/CIRCULATIONAHA.117.029190. Epub 2017 May 18. Circulation. 2017. PMID: 28522450 Free PMC article. Clinical Trial.
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer.
Harris RJ, Cheung A, Ng JCF, Laddach R, Chenoweth AM, Crescioli S, Fittall M, Dominguez-Rodriguez D, Roberts J, Levi D, Liu F, Alberts E, Quist J, Santaolalla A, Pinder SE, Gillett C, Hammar N, Irshad S, Van Hemelrijck M, Dunn-Walters DK, Fraternali F, Spicer JF, Lacy KE, Tsoka S, Grigoriadis A, Tutt ANJ, Karagiannis SN. Harris RJ, et al. Among authors: hammar n. Cancer Res. 2021 Aug 15;81(16):4290-4304. doi: 10.1158/0008-5472.CAN-20-3773. Epub 2021 Jun 15. Cancer Res. 2021. PMID: 34224371 Free PMC article.
Type 2 diabetes and heart failure: insights from the global DISCOVER study.
Arnold SV, Khunti K, Bonnet F, Charbonnel B, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes MB, Hammar N, Ji L, Luporini-Saraiva G, Medina J, Nicolucci A, Ramirez L, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Kosiborod M; DISCOVER investigators. Arnold SV, et al. Among authors: hammar n. ESC Heart Fail. 2021 Apr;8(2):1711-1716. doi: 10.1002/ehf2.13235. Epub 2021 Feb 11. ESC Heart Fail. 2021. PMID: 33570253 Free PMC article.
Cohort Profile: The AMORIS cohort.
Walldius G, Malmström H, Jungner I, de Faire U, Lambe M, Van Hemelrijck M, Hammar N. Walldius G, et al. Among authors: hammar n. Int J Epidemiol. 2017 Aug 1;46(4):1103-1103i. doi: 10.1093/ije/dyw333. Int J Epidemiol. 2017. PMID: 28158674 No abstract available.
Lipids, Apolipoproteins, and the Risk of Parkinson Disease.
Fang F, Zhan Y, Hammar N, Shen X, Wirdefeldt K, Walldius G, Mariosa D. Fang F, et al. Among authors: hammar n. Circ Res. 2019 Aug 30;125(6):643-652. doi: 10.1161/CIRCRESAHA.119.314929. Epub 2019 Aug 6. Circ Res. 2019. PMID: 31382822
252 results